HIV is still a significant problem for worldwide public health. The great majority of HIV-positive individuals reside in low- and middle-income nations. UNAIDs estimates that as of 2019, around 38.0 million individuals were living with AIDS worldwide. There were 1.7 million new infections. Cell sorting has been used in conjunction with molecular biology methods, proteomics, and single tumour cells to characterize metastatic and primary cancer cell groups across time. Globocan estimates that 19.29 million people will receive a new cancer diagnosis in 2020. According to the National Cancer Institute, 1,806,590 new instances of cancer are expected to be diagnosed in the United States year 2020, and 606,520 individuals will pass away from the disease.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/global-cell-sorting-market
Global cell sorting market is expected to reach USD 544.72 million by 2027 from USD 364.20 million in 2019, growing with the substantial CAGR of 5.3% in the forecast period of 2020 to 2027. Growing prevalence of cancer and HIV, increasing technological advancements in cell sorters, rising funding and investments for the development of innovative cell sorting techniques for advanced cell sorters, increasing research activities on cell sorting, wide acceptance of cell sorting techniques in various applications are the major drivers propelling the demand of the cell sorting market in the forecast period.
The growing prevalence of cancer across the world will drive the market's growth rate
Cancer disease has a major impact globally. Cancer statistics show that large groups of people are suffering from cancer worldwide. Statistics show that many people die from cancer each year, the appropriate treatment of cancer can cure cancer symptoms. The rising incidence of cancer such as lung, colorectal, breast, and liver cancer among more is expected to accelerate the cell sorting procedures for cancer research and thus, for this reason, the growing prevalence of cancer is acting as a driver for boosting the demand of the global cell sorting market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2020 to 2027
|
|
Base Year
|
2019
|
|
Historic Years
|
2018 (Customizable to 2013 - 2018)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product and Services (Cell Sorters, Reagents and Kits, Consumables, Cell Sorting Services), Technology (Fluorescence- Based Droplet Cell Sorting, Magnetic-Activated Cell Sorting (MACS), Micro-Electromechanical Systems (MEMS)–Microfluidics, Gradient Centrifugation, Immunodensity Cell Separation, Sedimentation, Cell Markers-Based, Buoyancy-Activated Cell Sorting (SACS), Others), Application (Research, Clinical), End User (Research Institutes, Pharmaceutical and Biotechnology Companies, Medical and Academic Institutions, Hospitals and Clinical Testing Laboratories, Diagnostic Laboratories, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
|
|
Market Players Covered
|
Molecular Machines and Industries GmbH (Germany), Miltenyi Biotec (Germany), Sony Biotechnology Inc. (U.S.), Union Biometrica, Inc. (U.S.), STEMCELL Technologies Inc. (Canada), TERUMO BCT, INC. (U.S.), Abgenex (India), Sysmex Europe GmbH (Germany), NanoCellect Biomedical (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cytonome/ST, LLC (U.S.), On-chip Biotechnologies Co., Ltd. (Japan), Beckman Coulter, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Luminex Corporation (U.S.), pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG (Germany), Cellular Highways (U.K.), Bay bioscience Co., Ltd. (Japan) among others.
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
Global cell sorting market is categorized into five notable segments which are based on product & services, technology, application, end user and distribution channel.
- On the basis of product & services, global cell sorting market is segmented into cell sorters, reagents & kits, cell sorting services and consumables. In 2020, cell sorters segment is expected to dominate the global cell sorting market with 45.42% market share due to the high adoption in research and diagnostic laboratories, academic and medical institutes, pharmaceutical & biotechnology companies for various applications such as immunology & cancer research, stem cell research, and drug discovery.
- On the basis of technology, global cell sorting market is segmented into fluorescence- based droplet cell sorting, magnetic-activated cell sorting (MACS), micro-electromechanical systems (MEMS) – microfluidics, gradient centrifugation, immunodensity cell separation, sedimentation, cell markers-based, buoyancy-activated cell sorting (SACS) and others. In 2020, fluorescence- based droplet cell sorting segment is expected to dominate the global cell sorting market with 34.46% market share due to the high usage of fluorescence- based cell sorters in various research laboratories and academic and medical institutes.
- On the basis of application, global cell sorting market is segmented into research and clinical. In 2020, research segment is expected to dominate the global cell sorting market with 63.23% market share due to the increasing usage of cell sorters for various applications such as immunology & cancer research, stem cell research and drug discovery.
- On the basis of end user, global cell sorting market is segmented into research institutes, pharmaceutical & biotechnology companies, medical & academic institutions, hospitals & clinical testing laboratories, diagnostic laboratories and others. In 2020, research institutes segment is expected to dominate the global cell sorting market with 43.18% market share due to the extensive use of cell sorters in research institutes for various applications such as immunology & cancer research, stem cell research and drug discovery.
The research institutes segment will dominate the end user segment of the cell sorting market
The research institutes segment will emerge as the dominating segment end user segment. This is because of the growing number of research institutes in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
- On the basis of distribution channel, global cell sorting market is segmented into direct tender and retail sales. In 2020, direct tender segment is expected to dominate the global cell sorting market with 54.25% market share due to the bulk purchasing cost of cell sorters which minimizes and is affordable for research institutes and pharmaceutical and biotechnology companies.
The direct tender segment will dominate the distribution channel segment of the cell sorting market
The direct tender segment will emerge as the dominating segment under distribution channel with approximately 54.00% market share. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in market: Molecular Machines and Industries GmbH (Germany), Miltenyi Biotec (Germany), Sony Biotechnology Inc. (U.S.), Union Biometrica, Inc. (U.S.), STEMCELL Technologies Inc. (Canada), TERUMO BCT, INC. (U.S.), Abgenex (India), Sysmex Europe GmbH (Germany), NanoCellect Biomedical (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cytonome/ST, LLC (U.S.), On-chip Biotechnologies Co., Ltd. (Japan), Beckman Coulter, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Luminex Corporation (U.S.), pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG (Germany), Cellular Highways (U.K.), Bay bioscience Co., Ltd. (Japan).
Market Development
- In January 2020, Miltenyi Biotec launched GMP-compliant cell sorting system, this is a new, advanced and first operator-free GMP-compliant cell sorting system
- In April 2019, Cellular Highways announced that they have launched Highway 1 which is an advanced technology based next-generation cell-sorting technology
- In April 2018, BD launched BD FACSymphony S6 cell sorter, this new product has ability to sort cell population to better understand cell phenotypes for multi-omics research as well as immunology
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
As per Data Bridge Market Research analysis:
North America is the dominant region in cell sorting market during the forecast period 2020 - 2027
North America dominates the cell sorting market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of advanced research infrastructures and growing government funding for research in this region.
Asia-Pacific is estimated to be the fastest-growing region in cell sorting market the forecast period 2020 - 2027
Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the rise in the medical tourism and increase in patient population in this region.
COVID-19 Impact
All research and development initiatives have been restricted by the pandemic to creating coronavirus-related medications and vaccines, with all other initiatives ending. As a result of a global labor shortage during the lockdown, several biotech and pharmaceutical businesses have suspended manufacturing. As a result of the corporations' interference with research projects and lower-than-anticipated purchases of cell sorters, the market growth has not been as anticipated. As a result of the rising incidence of cancer and HIV, the developing pharmaceutical and biotechnology sectors, and technological developments in cell sorters, the market for cell sorting will experience significant expansion.
For more detailed information about the cell sorting market, visit: https://www.databridgemarketresearch.com/ar/reports/global-cell-sorting-market
